Analyst Price Target is $37.00
▲ +234.84% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Yumanity Therapeutics in the last 3 months. The average price target is $37.00, with a high forecast of $39.00 and a low forecast of $35.00. The average price target represents a 234.84% upside from the last price of $11.05.
Current Consensus is
The current consensus among 3 investment analysts is to buy stock in Yumanity Therapeutics.